New ultrasound method could predict relapses in rare artery disease

NCT ID NCT07552636

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether ultrasound scans and patient questionnaires can better track disease activity in people with giant cell arteritis, a condition that inflames arteries and can cause blindness. Researchers will follow 175 patients in remission for one year, using ultrasound and blood samples to see if they can predict relapses. The goal is to improve monitoring and reduce reliance on steroids.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to better tools for monitoring giant cell arteritis and predicting relapses, helping doctors tailor treatments and reduce long-term steroid use.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. The tools tested may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Giant Cell Arteritis temporal arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aalborg University Hospital, Department of Rheumatology

    NOT_YET_RECRUITING

    Aalborg, 9000, Denmark

  • Aarhus University Hospital, Department of Rheumatology

    NOT_YET_RECRUITING

    Aarhus, 8200, Denmark

  • Hospitalsenhed Midt, Medicinsk Diagnostisk Center

    NOT_YET_RECRUITING

    Silkeborg, 8600, Denmark

  • Regional Hospital Horsens, Department of Medicine

    RECRUITING

    Horsens, 8700, Denmark

  • Rigshospitalet Glostrup, Center for Rheumatology and Spine Diseases Rigshospitalet

    NOT_YET_RECRUITING

    Glostrup Municipality, 2600, Denmark

  • Svendborg Hospital, Department of Medicine

    NOT_YET_RECRUITING

    Svendborg, 5700, Denmark

  • Vejle Hospital, Department of Medicine

    NOT_YET_RECRUITING

    Vejle, 7100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.